Therapy Areas: Diabetes
US FDA approves Trijardy XR
28 January 2020 - The United States Food and Drug Administration (FDA) has approved Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) to decrease blood sugar in ...
Poxel Names Moller as Chief Scientific Officer
24 January 2020 - - French biopharmaceutical company POXEL SA has appointed David E. Moller, MD, as chief scientific officer, the company said.

Moller will be responsible for leading...
Pfizer's Greenstone and Digital Men's Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra 
24 January 2020 - - US-based Greenstone, Upjohn's US-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, a digital healthcare clinic for men, have inked a supply agre...
Novo Nordisk receives FDA approval for Ozempic for CV risk reduction in people with type 2 diabetes and established CVD
17 January 2020 - Global health care company Novo Nordisk A/S (CPH:NOVOB) announced on Thursday the approval by the US Food and Drug Administration (FDA) of a label expansion based on a supplemental N...
Bon Secours Mercy Health collaborates with Lirio LLC
16 January 2020 - United States-based Bon Secours Mercy Health, a Catholic health care system, has collaborated with United States-based Lirio LLC, a behavioural engagement solution, it was reported y...
Foghorn Therapeutics Names Biller to Board of Directors
14 January 2020 - - US-based Foghorn Therapeutics Inc., a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulat...